IGC Pharma, Inc. Quarterly Marketable Securities, Current in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
IGC Pharma, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2020 to Q1 2023.
  • IGC Pharma, Inc. Marketable Securities, Current for the quarter ending March 31, 2023 was $154K.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $154K +$154K Mar 31, 2023 10-K 2023-07-07
Q2 2022 $0 $0 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $0 $0 Mar 31, 2022 10-K 2023-07-07
Q4 2021 $0 Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $0 Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $0 Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $0 -$5.08M -100% Mar 31, 2021 10-K 2022-06-23
Q1 2020 $5.08M Mar 31, 2020 10-K 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.